Physician profile
Eric Tabas
NPI 1194744722
$735.12
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $94.99 · 2021: $100 · 2024: $5.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $131.17 | 2019-2021 | |
| Aspira Women'S Health INC | $127.50 | 2019 | |
| Ethicon US, LLC | $125.10 | 2019 | |
| Merck Sharp & Dohme LLC | $120.19 | 2019 | |
| Abbvie INC. | $68.58 | 2019-2020 | |
| Therapeuticsmd, INC. | $67.76 | 2019 | |
| Mallinckrodt Enterprises LLC | $20.71 | 2019 | |
| Mayne Pharma Commercial LLC | $20.46 | 2021-2024 | |
| Exeltis, USA INC. | $19.08 | 2021 | |
| Roche Diagnostics Corporation | $17.93 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $16.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Tabas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.